Ocular Therapeutix (OCUL) Misses Q1 EPS by 2c

Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.40), $0.02 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• J.Jill (JILL) Tops Q2 EPS by 67c, Beats on Revenue; Offers Guidance
• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance